Skip to main content

Neutra Continues Rapid March Forward Latest LOI Points to New Hemp-based CBD Products and Markets

Written by Customer Service on . Posted in Public Companies.

SUGAR LAND, TX, Oct. 23, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neutra Corp. (OTC: NTRR) (“Neutra” or “the Company”), fresh off the recent release of a new cannabidiol (CBD) sports cream, has not rested in its efforts to press forward on its global mission. The Company has executed a game changing letter of intent (LOI) that, if executed as planned, may lead to the joint development of a wide variety of additional hemp-based medicinal products to serve the rapidly growing CBD market – a segment some analysts have predicted will soar to $11 billion by 2026. 
When completed, the agreement with Harrisburg, PA, based Orgaceutical Co would provide Neutra access to Orgaceutical’s formal research findings to investigate the use of cannabinoids as antioxidants and neuro-protectants. Neutra would also gain rights to a federally registered hemp trademark as well as a license for hemp cultivation issued by the Commonwealth of Pennsylvania’s Department of Agriculture. “This LOI will propel us into an excellent position for research and development of exciting new applications for hemp-based medicinal CBD products,” said Sydney Jim, Neutra’s CEO. “With the cultivation license, we’ll have a constant and consistent supply of quality hemp under a vertically integrated cultivation model. With the research license, we’ll be free to explore new uses for hemp and products derived from it. Finally, with the trademark, we’ll have a federally protected brand name to pair with our existing VIVIS product line.”   The noted investing website Motley Fool has predicted U.S. sales of CBD products will more than double every year between 2019 and 2023. Bloomberg has called hemp the “cannabis cash crop” thanks to the booming demand for the non-psychoactive CBD that can be derived from it. CBD is low in THC, the compound that gets users high. Because of its low THC level, hemp-based CBD is finding mainstream acceptance among a public eager for its medicinal value but not wanting the high that comes with other forms of cannabis. The LOI represents the latest step in Neutra’s efforts to become a vertically integrated company. The Company’s rapid forward progress in 2019 recently led Neutra to cancel a planned reverse split, which had become unnecessary amid so much recent traction. About Neutra Corp.Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one wherein which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at www.NeutraInc.com.NOTICE REGARDING FORWARD LOOKING STATEMENT Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.Neutra Contact:

Sydney Jim
888-433-4033
info@neutrainc.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.